- Home
- EXAS vs AUR Comparison
EXAS vs AUR Comparison
Compare EXAS & AUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- AUR
- Stock Information
- Founded
- EXAS 1995
- AUR 2017
- Country
- EXAS United States
- AUR United States
- Employees
- EXAS N/A
- AUR N/A
- Industry
- EXAS Medical Specialities
- AUR EDP Services
- Sector
- EXAS Health Care
- AUR Technology
- Exchange
- EXAS Nasdaq
- AUR Nasdaq
- Market Cap
- EXAS 11.0B
- AUR 9.9B
- IPO Year
- EXAS N/A
- AUR N/A
- Fundamental
- Price
- EXAS $100.87
- AUR $3.78
- Analyst Decision
- EXAS Strong Buy
- AUR Buy
- Analyst Count
- EXAS 18
- AUR 9
- Target Price
- EXAS $72.44
- AUR $10.44
- AVG Volume (30 Days)
- EXAS 7.2M
- AUR 19.4M
- Earning Date
- EXAS 11-03-2025
- AUR 10-28-2025
- Dividend Yield
- EXAS N/A
- AUR N/A
- EPS Growth
- EXAS N/A
- AUR N/A
- EPS
- EXAS N/A
- AUR N/A
- Revenue
- EXAS $3,082,033,000.00
- AUR $2,000,000.00
- Revenue This Year
- EXAS $16.68
- AUR N/A
- Revenue Next Year
- EXAS $12.36
- AUR $939.88
- P/E Ratio
- EXAS N/A
- AUR N/A
- Revenue Growth
- EXAS 14.47
- AUR N/A
- 52 Week Low
- EXAS $38.81
- AUR $3.69
- 52 Week High
- EXAS $101.87
- AUR $10.77
- Technical
- Relative Strength Index (RSI)
- EXAS 91.11
- AUR 23.39
- Support Level
- EXAS $66.00
- AUR $3.69
- Resistance Level
- EXAS $69.08
- AUR $4.38
- Average True Range (ATR)
- EXAS 3.80
- AUR 0.26
- MACD
- EXAS 2.49
- AUR -0.05
- Stochastic Oscillator
- EXAS 97.30
- AUR 4.61
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About AUR Aurora Innovation Inc.
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.